Tuas, Singapore

Wuxi STA

Tuas, Singapore

API Process Development and Manufacturing

Coming soon. The new 50-acre site will offer API manufacturing from preclinical stages to commercial manufacturing.

Phase I of the project includes 2 plants, with a total reactor volume (TRV) exceeding 350 m³. The site is expected to start operation in 2027.

Site Virtual Tour

How can we help?

Oligonucleotide or Peptide Projects?

Scroll to Top
Please enable JavaScript in your browser to complete this form.